Active ingredientCinchocaineCat. No. P-C167-001CAS 85-79-0Family · Pharmaceutical analytical standards
Cinchocaine
An amide-type local anaesthetic derived from quinoline, in clinical use since around 1930: it is among the most potent and long-lasting of its class and is used in haemorrhoid creams and in spinal anaesthesia. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It gives its name to the dibucaine number, a test devised in 1957 that measures how much it blocks blood cholinesterase, revealing people with an enzyme variant that clears some muscle relaxants slowly.
Go to the active ingredient →Active ingredientCinchocaineCat. No. P-C167-001CAS 85-79-0
Active ingredientCinchocaine HydrochlorideCat. No. P-C167-002CAS 61-12-1
Pharmacopoeial impurityCinchocaine EP Impurity ACat. No. P-C167-003CAS 87864-14-0
Pharmacopoeial impurityCinchocaine EP Impurity BCat. No. P-C167-004CAS 15733-89-8
Pharmacopoeial impurityCinchocaine EP Impurity CCat. No. P-C167-005CAS 87864-08-2
Pharmacopoeial impurityDibucaine Impurity DCat. No. P-C167-006CAS 10222-61-4
ImpurityCinchocaine Impurity 1Cat. No. P-C167-007CAS 51842-70-7
ImpurityCinchocaine Impurity 2Cat. No. P-C167-008CAS 84906-82-1
ImpurityCinchocaine N-OxideCat. No. P-C167-009CAS 87864-07-1
ImpurityDesethyl CinchocaineCat. No. P-C167-010CAS 87864-11-7No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceCinchocaine hydrochloride CRSEDQM code C2177000Family CinchocaineImpurityCinchocaine impurity A CRSEDQM code Y0002033Family CinchocaineImpurityCinchocaine impurity B CRSEDQM code Y0002032Family CinchocaineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.